Fig. 1From: Poor outcomes of immunoglobulin D multiple myeloma patients in the era of novel agents: a single-center experiencea Duration of response in patients with IgD subtype or non-IgD subtypes of multiple myeloma, b Kaplan–Meier progression-free survival curves of patients with IgD subtype or non-IgD subtypes of multiple myeloma, c Kaplan–Meier overall survival curves of patients with IgD subtype or non-IgD subtypes of multiple myelomaBack to article page